// App-Quantinova.ai

PO1932 : Extended Follow-Up of Patients Recruited to a Randomized, Controlled Trial of Rituximab vs. Azathioprine, After Rituximab Remission Induction for Patients with Relapsing ANCA-Associated Vasculitis

Researchers

Presenter

  • Smith RonaM

Principal Investigators

  • Jayne DavidR.W

  • Merkel PeterA

Medical Centers

  • University of Cambridge Cambridge Cambridgeshire United Kingdom

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Genetic Disorder

Disease

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

  • Oraprine

  • Rituximab

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved